Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
26%
upside
4 price targets
|
0
%
|
|
|
|
26%
upside
5 price targets
|
0
%
|
|
|
|
26%
upside
6 price targets
|
0
%
|
|
|
129
Apogee Therapeutics
APGE
$6.26B
|
26%
upside
3 price targets
|
0
%
|
|
|
26%
upside
3 price targets
|
0
%
|
|
|
|
26%
upside
3 price targets
|
0
%
|
|
|
|
26%
upside
11 price targets
|
0
%
|
|
|
|
26%
upside
3 price targets
|
0
%
|
|
|
|
25%
upside
9 price targets
|
0
%
|
|
|
|
25%
upside
3 price targets
|
0
%
|
|
|
136
Teradata
TDC
$2.99B
|
25%
upside
5 price targets
|
0
%
|
|
|
25%
upside
5 price targets
|
0
%
|
|
|
|
24%
upside
14 price targets
|
0
%
|
|
|
|
24%
upside
3 price targets
|
0
%
|
|
|
|
24%
upside
3 price targets
|
0
%
|
|
|
|
24%
upside
5 price targets
|
0
%
|
|
|
|
23%
upside
4 price targets
|
0
%
|
|
|
|
23%
upside
5 price targets
|
0
%
|
|
|
|
23%
upside
3 price targets
|
0
%
|
|
|
|
23%
upside
4 price targets
|
0
%
|
|
|
|
23%
upside
4 price targets
|
0
%
|
|
|
|
23%
upside
6 price targets
|
0
%
|
|
|
|
22%
upside
3 price targets
|
0
%
|
|
|
|
21%
upside
3 price targets
|
0
%
|
|
|
|
21%
upside
4 price targets
|
0
%
|
|